휴대용 부정맥 모니터링 기기 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of ambulatory arrhythmia monitoring devices Market

The global ambulatory arrhythmia monitoring devices market is experiencing substantial growth, driven by a rising prevalence of cardiovascular disorders, increasing geriatric population, and technological advancements in cardiac monitoring. These devices are primarily used to monitor abnormal heart rhythms over extended periods in settings such as hospitals, ambulatory surgical centers (ASCs), clinics, and home care environments. Conditions such as atrial fibrillation, tachycardia, bradycardia, and ventricular fibrillation are fostering demand for effective diagnostic and monitoring solutions worldwide.

In 2025, the market was valued at USD 6.6 billion and is projected to grow to USD 7.03 billion in 2026 and reach USD 12.28 billion by 2034, registering a CAGR of 7.21% during 2026-2034. North America dominated the market in 2025 with a 46.58% share, attributed to government initiatives, favorable reimbursement policies, and the launch of advanced monitoring devices by key players such as Abbott, Medtronic, and Boston Scientific.

Market Drivers and Trends

Increasing Prevalence of Cardiovascular Disorders

The rising geriatric population and the increasing incidence of arrhythmia among older adults are key market drivers. For instance, approximately 5.3 million people in the U.S. suffer from atrial fibrillation, and in Germany, 1.5 million people are affected, resulting in significant healthcare expenditure. These trends are driving adoption of ambulatory monitoring devices to improve diagnostic accuracy and patient outcomes.

Technological Advancements

The shift toward wearable and smart monitoring devices is transforming the market. Devices such as Abbott's Jot Dx insertable cardiac monitor and LIVMOR Halo's FDA-approved atrial fibrillation detection system are enabling remote and real-time monitoring, which improves patient compliance and reduces clinic visits. The non-invasive nature of external monitors and the increasing preference for smart wearables are fueling market growth.

Post-COVID-19 Recovery

The market witnessed a decline during the COVID-19 pandemic due to limited clinical visits and postponed elective procedures. Revenue of major companies, including Abbott and Medtronic, dropped by approximately 10-12% in 2020. However, adoption is rebounding rapidly as healthcare services normalize and telehealth solutions complement monitoring.

Market Segmentation Analysis

By Device Type

• Holter monitors dominated in 2026 with a 55.16% share, due to cost-effectiveness and widespread reimbursement coverage.
• Mobile cardiac telemetry devices are expected to register the highest CAGR, offering real-time monitoring and high diagnostic yield.

By Type

• External monitors accounted for 74.88% of the market in 2026, primarily due to their non-invasive nature and lower cost.
• Implantable monitors are projected to grow moderately, supported by long-term monitoring capabilities and advanced technological features.

By Application

• Atrial fibrillation segment led the market in 2026 with a 49.04% share, driven by its high prevalence globally.
• Ventricular fibrillation segment is expected to record the highest CAGR due to increasing awareness and associated health risks.

By End-User

• Diagnostic centers and clinics dominated in 2026 with a 54.22% share, benefiting from advanced monitoring devices and trained personnel.
• Hospitals and ASCs held the second-largest share due to multispecialty care units and comprehensive arrhythmia management services.

Regional Insights

North America: Market size was USD 3.08 billion in 2025, with the U.S. projected to reach USD 2.81 billion in 2026, driven by awareness campaigns and strong healthcare infrastructure.

Europe: Growth is driven by a large geriatric population and advanced healthcare systems. The UK market is projected at USD 0.41 billion in 2026 and Germany at USD 0.57 billion.

Asia Pacific: Expected to register the highest CAGR, with Japan at USD 0.27 billion, China at USD 0.51 billion, and India at USD 0.25 billion in 2026, due to increasing arrhythmia prevalence and growing patient pool.

Latin America and Middle East & Africa: Anticipated moderate growth due to limited awareness and developing healthcare infrastructure.

Key Players

Major players include Abbott, Medtronic, Boston Scientific, BioTelemetry, iRhythm Technologies, Medi-Lynx Cardiac Monitoring, ZOLL Medical, and CamNtech Ltd. These companies focus on innovative devices, insertable cardiac monitors, and partnerships to expand market presence. For instance, Boston Scientific obtained pre-marketing approval for LUX-Dx insertable cardiac monitors in 2020, while iRhythm partnered with Verily to provide early warnings for asymptomatic atrial fibrillation.

Conclusion

The ambulatory arrhythmia monitoring devices market is projected to grow from USD 6.6 billion in 2025 to USD 12.28 billion by 2034, fueled by rising prevalence of cardiovascular disorders, technological innovations in remote monitoring, and expanding geriatric populations. Despite challenges such as high device costs and occasional faulty measurements, the increasing adoption of wearable smart devices, supportive reimbursement policies, and expanding healthcare infrastructure are expected to sustain growth. North America will remain dominant, while Asia Pacific is poised to emerge as the fastest-growing region.

Segmentation By Device type

• Holter Monitors
• Event Monitors
• Mobile Cardiac Telemetry Monitors

By Type

• External
• Implantable

By Application

• Tachycardia
• Bradycardia
• Atrial Fibrillation
• Ventricular Fibrillation
• Others

By End-user

• Hospitals and ASCs
• Diagnostics Centers and Clinics
• Others

By Geography

• North America (By Device Type, By Type, By Application, By End-user, and By Country)
  • U.S. (By Application)
  • Canada (By Application)
• Europe (By Device Type, By Type, By Application, By End-user, and By Country)
  • U.K. (By Application)
  • Germany (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Scandinavia (By Application)
  • Rest of Europe (By Application)
• Asia Pacific (By Device Type, By Type, By Application, By End-user, and By Country)
  • Japan (By Application)
  • China (By Application)
  • India (By Application)
  • Australia (By Application)
  • Southeast Asia (By Application)
  • Rest of Asia Pacific (By Application)
• Latin America (By Device Type, By Type, By Application, By End-user, and By Country)
  • Brazil (By Application)
  • Mexico (By Application)
  • Rest of Latin America (By Application)
• Middle East & Africa (By Device Type, By Type, By Application, By End-user, and By Country)
  • South Africa (By Application)
  • GCC (By Application)
  • Rest of Middle East & Africa (By Application)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Number of Key Cardiovascular Disorders, By Region/Country, 2025
• 4.2. New Product Launches, By Key Players
• 4.3. Impact of COVID-19 on the Market
• 4.4. Recent Key Developments, Mergers, and Acquisitions, Key Players

5. Global Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2025-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Device Type
  • 5.2.1. Holter Monitors
  • 5.2.2. Event Monitors
  • 5.2.3. Mobile Cardiac Telemetry Monitors
• 5.3. Market Analysis, Insights and Forecast - By Type
  • 5.3.1. External
  • 5.3.2. Implantable
• 5.4. Market Analysis, Insights and Forecast - By Application
  • 5.4.1. Tachycardia
  • 5.4.2. Bradycardia
  • 5.4.3. Atrial Fibrillation
  • 5.4.4. Ventricular Fibrillation
  • 5.4.5. Others
• 5.5. Market Analysis, Insights and Forecast - By End User
  • 5.5.1. Hospitals and ASCs
  • 5.5.2. Diagnostics Centers and Clinics
  • 5.5.3. Others
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2025-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Device Type
  • 6.2.1. Holter Monitors
  • 6.2.2. Event Monitors
  • 6.2.3. Mobile Cardiac Telemetry Monitors
• 6.3. Market Analysis, Insights and Forecast - By Type
  • 6.3.1. External
  • 6.3.2. Implantable
• 6.4. Market Analysis, Insights and Forecast - By Application
  • 6.4.1. Tachycardia
  • 6.4.2. Bradycardia
  • 6.4.3. Atrial Fibrillation
  • 6.4.4. Ventricular Fibrillation
  • 6.4.5. Others
• 6.5. Market Analysis, Insights and Forecast - By End User
  • 6.5.1. Hospitals and ASCs
  • 6.5.2. Diagnostics Centers and Clinics
  • 6.5.3. Others
• 6.6. Market Analysis, Insights and Forecast - By Country
  • 6.6.1. U.S.
    • 6.6.1.1. By Application
  • 6.6.2. Canada
    • 6.6.2.1. By Application

7. Europe Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2025-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Device Type
  • 7.2.1. Holter Monitors
  • 7.2.2. Event Monitors
  • 7.2.3. Mobile Cardiac Telemetry Monitors
• 7.3. Market Analysis, Insights and Forecast - By Type
  • 7.3.1. External
  • 7.3.2. Implantable
• 7.4. Market Analysis, Insights and Forecast - By Application
  • 7.4.1. Tachycardia
  • 7.4.2. Bradycardia
  • 7.4.3. Atrial Fibrillation
  • 7.4.4. Ventricular Fibrillation
  • 7.4.5. Others
• 7.5. Market Analysis, Insights and Forecast - By End User
  • 7.5.1. Hospitals and ASCs
  • 7.5.2. Diagnostics Centers and Clinics
  • 7.5.3. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.6.1. U.K
    • 7.6.1.1. By Application
  • 7.6.2. Germany
    • 7.6.2.1. By Application
  • 7.6.3. France
    • 7.6.3.1. By Application
  • 7.6.4. Spain
    • 7.6.4.1. By Application
  • 7.6.5. Italy
    • 7.6.5.1. By Application
  • 7.6.6. Scandinavia
    • 7.6.6.1. By Application
  • 7.6.7. Rest of Europe
    • 7.6.7.1. By Application

8. Asia Pacific Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2025-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Device Type
  • 8.2.1. Holter Monitors
  • 8.2.2. Event Monitors
  • 8.2.3. Mobile Cardiac Telemetry Monitors
• 8.3. Market Analysis, Insights and Forecast - By Type
  • 8.3.1. External
  • 8.3.2. Implantable
• 8.4. Market Analysis, Insights and Forecast - By Application
  • 8.4.1. Tachycardia
  • 8.4.2. Bradycardia
  • 8.4.3. Atrial Fibrillation
  • 8.4.4. Ventricular Fibrillation
  • 8.4.5. Others
• 8.5. Market Analysis, Insights and Forecast - By End User
  • 8.5.1. Hospitals and ASCs
  • 8.5.2. Diagnostics Centers and Clinics
  • 8.5.3. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.6.1. Japan
    • 8.6.1.1. By Application
  • 8.6.2. China
    • 8.6.2.1. By Application
  • 8.6.3. India
    • 8.6.3.1. By Application
  • 8.6.4. Australia
    • 8.6.4.1. By Application
  • 8.6.5. Southeast Asia
    • 8.6.5.1. By Application
  • 8.6.6. Rest of Asia Pacific
    • 8.6.6.1. By Application

9. Latin America Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2025-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Device Type
  • 9.2.1. Holter Monitors
  • 9.2.2. Event Monitors
  • 9.2.3. Mobile Cardiac Telemetry Monitors
• 9.3. Market Analysis, Insights and Forecast - By Type
  • 9.3.1. External
  • 9.3.2. Implantable
• 9.4. Market Analysis, Insights and Forecast - By Application
  • 9.4.1. Tachycardia
  • 9.4.2. Bradycardia
  • 9.4.3. Atrial Fibrillation
  • 9.4.4. Ventricular Fibrillation
  • 9.4.5. Others
• 9.5. Market Analysis, Insights and Forecast - By End User
  • 9.5.1. Hospitals and ASCs
  • 9.5.2. Diagnostics Centers and Clinics
  • 9.5.3. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.6.1. Brazil
    • 9.6.1.1. By Application
  • 9.6.2. Mexico
    • 9.6.2.1. By Application
  • 9.6.3. Rest of Latin America
    • 9.6.3.1. By Application

10. Middle East & Africa Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2025-2034

• 10.1. Market Analysis, Insights and Forecast - By Device Type
  • 10.1.1. Holter Monitors
  • 10.1.2. Event Monitors
  • 10.1.3. Mobile Cardiac Telemetry Monitors
• 10.2. Market Analysis, Insights and Forecast - By Type
  • 10.2.1. External
  • 10.2.2. Implantable
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Tachycardia
  • 10.3.2. Bradycardia
  • 10.3.3. Atrial Fibrillation
  • 10.3.4. Ventricular Fibrillation
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals and ASCs
  • 10.4.2. Diagnostics Centers and Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.5.1. GCC
    • 10.5.1.1. By Application
  • 10.5.2. South Africa
    • 10.5.2.1. By Application
  • 10.5.3. Rest of Middle East & Africa
    • 10.5.3.1. By Application

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  • 11.3.1. Abbott
    • 11.3.1.1. Overview,
    • 11.3.1.2. Products,
    • 11.3.1.3. SWOT Analysis,
    • 11.3.1.4. Recent Developments,
    • 11.3.1.5. Strategies,
    • 11.3.1.6. financials (Based on Availability)
  • 11.3.2. Medtronic
    • 11.3.2.1. Overview,
    • 11.3.2.2. Products,
    • 11.3.2.3. SWOT Analysis,
    • 11.3.2.4. Recent Developments,
    • 11.3.2.5. Strategies,
    • 11.3.2.6. financials (Based on Availability)
  • 11.3.3. Boston Scientific Corporation
    • 11.3.3.1. Overview,
    • 11.3.3.2. Products,
    • 11.3.3.3. SWOT Analysis,
    • 11.3.3.4. Recent Developments,
    • 11.3.3.5. Strategies,
    • 11.3.3.6. financials (Based on Availability)
  • 11.3.4. BioTelemetry
    • 11.3.4.1. Overview,
    • 11.3.4.2. Products,
    • 11.3.4.3. SWOT Analysis,
    • 11.3.4.4. Recent Developments,
    • 11.3.4.5. Strategies,
    • 11.3.4.6. financials (Based on Availability)
  • 11.3.5. iRhythm Technologies, Inc.
    • 11.3.5.1. Overview,
    • 11.3.5.2. Products,
    • 11.3.5.3. SWOT Analysis,
    • 11.3.5.4. Recent Developments,
    • 11.3.5.5. Strategies,
    • 11.3.5.6. financials (Based on Availability)
  • 11.3.6. Medi-Lynx Cardiac Monitoring, LLC.
    • 11.3.6.1. Overview,
    • 11.3.6.2. Products,
    • 11.3.6.3. SWOT Analysis,
    • 11.3.6.4. Recent Developments,
    • 11.3.6.5. Strategies,
    • 11.3.6.6. financials (Based on Availability)
  • 11.3.7. CamNtech Ltd
    • 11.3.7.1. Overview,
    • 11.3.7.2. Products,
    • 11.3.7.3. SWOT Analysis,
    • 11.3.7.4. Recent Developments,
    • 11.3.7.5. Strategies,
    • 11.3.7.6. financials (Based on Availability)
  • 11.3.8. ZOLL Medical Corporation
    • 11.3.8.1. Overview,
    • 11.3.8.2. Products,
    • 11.3.8.3. SWOT Analysis,
    • 11.3.8.4. Recent Developments,
    • 11.3.8.5. Strategies,
    • 11.3.8.6. financials (Based on Availability)